View in EDS HTML Full Text PDF Full Text

A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML.

Saved in:
Bibliographic Details
Title: A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML.
Authors: Lontos, Konstantinos1 (AUTHOR), Tsagianni, Anastasia1 (AUTHOR), Agha, Mounzer1 (AUTHOR), Raptis, Anastasios1 (AUTHOR), Hou, Jing-Zhou1 (AUTHOR), Farah, Rafic1 (AUTHOR), Redner, Robert L.1 (AUTHOR), Im, Annie1 (AUTHOR), Dorritie, Kathleen A.1 (AUTHOR), Sehgal, Alison1 (AUTHOR), Rossetti, James1 (AUTHOR), Aggarwal, Nidhi2 (AUTHOR), Saul, Melissa3 (AUTHOR), Gooding, William4 (AUTHOR), Boyiadzis, Michael1 (AUTHOR)
Source: Leukemia & Lymphoma. Dec2022, Vol. 63 Issue 13, p3257-3260. 4p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428194.2022.2118532